Investigational Device Exemption Application Submitted to FDA for Freedom(TM) Discharge Driver to Power SynCardia Systems, Inc. Total Artificial Heart

TUCSON, Ariz.--(BUSINESS WIRE)--On Nov. 5, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced it has submitted an application to the FDA to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ discharge driver, designed to power the Total Artificial Heart outside the hospital.